Covid-19 and Hematological Malignancies What we have to know?

Nahla A M Hamed
Additional contact information
Nahla A M Hamed: Hematology Department, Faculty of Medicine, Alexandria University, Egypt

Cancer Therapy & Oncology International Journal, 2020, vol. 16, issue 4, 63-67

Abstract: Cancers of blood and bone marrow often directly compromise the immune system. Patients with blood cancers are particularly vulnerable to serious illness if they become infected with severe acute respiratory syndrome corona virus 2. Furthermore, the death rate was high among patients with hematological cancers. COVID-19 testing may be a reasonable advice even in asymptomatic patients who will receive immunosuppressive anticancer therapy to guide treatment decision making. Modifying or withholding therapy should be individualized. Factors such as chemotherapy indication, the goals of cancer care as well as where the patient is in the treatment course and the number of chemotherapy cycles given to the patients should be considered.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555942.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555942.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:16:y:2020:i:4:p:63-67

DOI: 10.19080/CTOIJ.2020.16.555942

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().